| Literature DB >> 30017389 |
Cristiana Santos de Macedo1, Fernanda Marques de Carvalho2, Julio Jablonski Amaral3, Soraya de Mendonça Ochs4, Edson F Assis5, Euzenir Nunes Sarno6, Patrícia Torres Bozza5, Maria Cristina Vidal Pessolani2.
Abstract
The disease leprosy is caused by Mycobacterium leprae. The disease displays a spectrum of clinical manifestations relating to the stage of the infection and the pathogen-specific immune response. The most frequent M. leprae-specific hypersensitivity reactions are erythema nodosum leprosum (ENL) and type-1 (reversal) reaction (T1R). Omega-3 and omega-6 fatty acid-derived lipid mediators are involved in the regulation of these M. leprae-specific inflammatory and immune responses. Studies on lipid mediators showed their presence during different manifestations of leprosy-before and after multidrug therapy (MDT) and during T1R. This review aims to compare the lipid mediators at different stages of the disease. This review also presents new data on the significance of lipid mediators (cysteinyl leukotrienes and leukotriene B4, prostaglandin E2 and D2, lipoxin A4 and resolvin D1) on ENL.Entities:
Keywords: Docosanoids; Eicosanoids; Erythema nodosum leprosum; Mycobacterium leprae; Polyunsaturated fatty acids
Mesh：
Substances：
Year: 2018 PMID： 30017389 DOI： 10.1016/j.cyto.2018.07.008
Source DB: PubMed Journal: Cytokine ISSN： 1043-4666 Impact factor: 3.861